Blockade of the interaction between Bcr-Abl and PTB1B by small molecule SBF-1 to overcome imatinib-resistance of chronic myeloid leukemia cellsAhmed Elgehama, Qiang Xu, Jiahuang Li et al.|Cancer Letters|2015Cited by 19
Targeting the <scp>PTP1B‐Bcr‐Abl1</scp> interaction for the degradation of <scp>T315I</scp> mutant <scp>Bcr‐Abl1</scp> in chronic myeloid leukemiaAhmed Elgehama, Qiang Xu, Yixuan Wang et al.|Cancer Science|2022Cited by 5
Identification of a RIPK2-Regulated Gene Signature as a Candidate Biomarker for RIPK2 Activity and Prognosis in Prostate CancerAhmed Elgehama, Wei Yang|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0